Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-02-27

AUTHORS

Yuko Matsui, Atsushi Suzuki, Tsuyoshi Shiga, Kotaro Arai, Nobuhisa Hagiwara

ABSTRACT

OBJECTIVE: Atrial tachyarrhythmias (ATAs) lead to clinical deterioration and worsening heart failure (HF) in patients with acute decompensated HF (ADHF). We evaluated the effects of the ultrashort-acting intravenous β1-blocker landiolol on the heart rate, hemodynamics, and outcome in patients with ATAs and ADHF. METHODS: A total of 67 consecutive hospitalized patients with ATAs and ADHF who were treated with landiolol (36 males, 67 ± 12 years) were included in this single-center retrospective study. The primary endpoints were changes in heart rate and systolic blood pressure from baseline during intravenous landiolol administration. The secondary endpoints included restoration of sinus rhythm and outcomes. RESULTS: The median maintenance dose of intravenous landiolol was 3.0 (range 1.0-12.0) μg/kg/min and the median treatment duration was 5 (range 1-24) days. Intravenous landiolol reduced heart rate (141 ± 17 beats/min at baseline to 99 ± 20 beats/min at 6 h, P < 0.001) without a marked reduction in blood pressure or deterioration of HF. During landiolol treatment, 15 (22%) patients had spontaneously restored sinus rhythm. Eight patients experienced in-hospital death, and 41 (69%) were discharged with sinus rhythm. During the follow-up of 16 ± 12 months, patients with sinus rhythm showed a lower frequency of rehospitalization due to worsening HF than patients with ATAs (5/41 vs. 7/18, P = 0.019). CONCLUSIONS: Our results showed that intravenous landiolol reduces the heart rate without markedly decreasing blood pressure in patients with ATAs and ADHF. Approximately 70% of the discharged patients were in sinus rhythm, and these patients showed a lower frequency of rehospitalization due to worsening HF (UMIN-CTR no. UMIN000033650). More... »

PAGES

19-26

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1

DOI

http://dx.doi.org/10.1007/s40801-019-0149-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112400550

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30810944


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsui", 
        "givenName": "Yuko", 
        "id": "sg:person.010405336441.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010405336441.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Atsushi", 
        "id": "sg:person.01021613072.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021613072.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shiga", 
        "givenName": "Tsuyoshi", 
        "id": "sg:person.01273642053.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273642053.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arai", 
        "givenName": "Kotaro", 
        "id": "sg:person.01315321616.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315321616.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan", 
          "id": "http://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "Department of Cardiology, Tokyo Women\u2019s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hagiwara", 
        "givenName": "Nobuhisa", 
        "id": "sg:person.01204734316.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204734316.73"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s40265-018-0883-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101176136", 
          "https://doi.org/10.1007/s40265-018-0883-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40256-018-0276-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103175695", 
          "https://doi.org/10.1007/s40256-018-0276-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-013-0377-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020627110", 
          "https://doi.org/10.1007/s00380-013-0377-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03016588", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029531145", 
          "https://doi.org/10.1007/bf03016588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40265-013-0077-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030203642", 
          "https://doi.org/10.1007/s40265-013-0077-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-02-27", 
    "datePublishedReg": "2019-02-27", 
    "description": "OBJECTIVE: Atrial tachyarrhythmias (ATAs) lead to clinical deterioration and worsening heart failure (HF) in patients with acute decompensated HF (ADHF). We evaluated the effects of the ultrashort-acting intravenous \u03b21-blocker landiolol on the heart rate, hemodynamics, and outcome in patients with ATAs and ADHF.\nMETHODS: A total of 67 consecutive hospitalized patients with ATAs and ADHF who were treated with landiolol (36 males, 67\u2009\u00b1\u200912\u00a0years) were included in this single-center retrospective study. The primary endpoints were changes in heart rate and systolic blood pressure from baseline during intravenous landiolol administration. The secondary endpoints included restoration of sinus rhythm and outcomes.\nRESULTS: The median maintenance dose of intravenous landiolol was 3.0 (range 1.0-12.0) \u03bcg/kg/min and the median treatment duration was 5 (range 1-24) days. Intravenous landiolol reduced heart rate (141\u2009\u00b1\u200917 beats/min at baseline to 99\u2009\u00b1\u200920 beats/min at 6\u00a0h, P\u2009<\u20090.001) without a marked reduction in blood pressure or deterioration of HF. During landiolol treatment, 15 (22%) patients had spontaneously restored sinus rhythm. Eight patients experienced in-hospital death, and 41 (69%) were discharged with sinus rhythm. During the follow-up of 16\u2009\u00b1\u200912\u00a0months, patients with sinus rhythm showed a lower frequency of rehospitalization due to worsening HF than patients with ATAs (5/41 vs. 7/18, P\u2009=\u20090.019).\nCONCLUSIONS: Our results showed that intravenous landiolol reduces the heart rate without markedly decreasing blood pressure in patients with ATAs and ADHF. Approximately 70% of the discharged patients were in sinus rhythm, and these patients showed a lower frequency of rehospitalization due to worsening HF (UMIN-CTR no. UMIN000033650).", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40801-019-0149-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1051855", 
        "issn": [
          "2199-1154", 
          "2198-9788"
        ], 
        "name": "Drugs - Real World Outcomes", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "keywords": [
      "acute decompensated HF", 
      "acute decompensated heart failure", 
      "decompensated heart failure", 
      "heart failure", 
      "sinus rhythm", 
      "intravenous landiolol", 
      "heart rate", 
      "blood pressure", 
      "deterioration of HF", 
      "single-center retrospective study", 
      "median treatment duration", 
      "single-center experience", 
      "systolic blood pressure", 
      "median maintenance dose", 
      "reduced heart rate", 
      "landiolol administration", 
      "landiolol treatment", 
      "Secondary endpoints", 
      "hospital death", 
      "clinical deterioration", 
      "primary endpoint", 
      "maintenance dose", 
      "atrial tachyarrhythmias", 
      "retrospective study", 
      "landiolol", 
      "patients", 
      "treatment duration", 
      "marked reduction", 
      "rehospitalization", 
      "rhythm", 
      "endpoint", 
      "outcomes", 
      "low frequency", 
      "tachyarrhythmias", 
      "failure", 
      "hemodynamics", 
      "administration", 
      "dose", 
      "baseline", 
      "deterioration", 
      "months", 
      "rate", 
      "death", 
      "treatment", 
      "total", 
      "pressure", 
      "duration", 
      "days", 
      "effect", 
      "min", 
      "frequency", 
      "restoration", 
      "study", 
      "reduction", 
      "experience", 
      "changes", 
      "lead", 
      "results", 
      "ATAS", 
      "Atrial tachyarrhythmias (ATAs) lead", 
      "tachyarrhythmias (ATAs) lead", 
      "ultrashort-acting intravenous \u03b21-blocker landiolol", 
      "intravenous \u03b21-blocker landiolol", 
      "\u03b21-blocker landiolol", 
      "intravenous landiolol administration", 
      "Intravenous landiolol reduced heart rate", 
      "landiolol reduced heart rate"
    ], 
    "name": "Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience", 
    "pagination": "19-26", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112400550"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40801-019-0149-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30810944"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40801-019-0149-1", 
      "https://app.dimensions.ai/details/publication/pub.1112400550"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_796.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40801-019-0149-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40801-019-0149-1'


 

This table displays all metadata directly associated to this object as RDF triples.

177 TRIPLES      22 PREDICATES      98 URIs      85 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40801-019-0149-1 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nee9683b7d3c54dc1b14bfc0892e3d8b9
4 schema:citation sg:pub.10.1007/bf03016588
5 sg:pub.10.1007/s00380-013-0377-3
6 sg:pub.10.1007/s40256-018-0276-1
7 sg:pub.10.1007/s40265-013-0077-4
8 sg:pub.10.1007/s40265-018-0883-9
9 schema:datePublished 2019-02-27
10 schema:datePublishedReg 2019-02-27
11 schema:description OBJECTIVE: Atrial tachyarrhythmias (ATAs) lead to clinical deterioration and worsening heart failure (HF) in patients with acute decompensated HF (ADHF). We evaluated the effects of the ultrashort-acting intravenous β1-blocker landiolol on the heart rate, hemodynamics, and outcome in patients with ATAs and ADHF. METHODS: A total of 67 consecutive hospitalized patients with ATAs and ADHF who were treated with landiolol (36 males, 67 ± 12 years) were included in this single-center retrospective study. The primary endpoints were changes in heart rate and systolic blood pressure from baseline during intravenous landiolol administration. The secondary endpoints included restoration of sinus rhythm and outcomes. RESULTS: The median maintenance dose of intravenous landiolol was 3.0 (range 1.0-12.0) μg/kg/min and the median treatment duration was 5 (range 1-24) days. Intravenous landiolol reduced heart rate (141 ± 17 beats/min at baseline to 99 ± 20 beats/min at 6 h, P < 0.001) without a marked reduction in blood pressure or deterioration of HF. During landiolol treatment, 15 (22%) patients had spontaneously restored sinus rhythm. Eight patients experienced in-hospital death, and 41 (69%) were discharged with sinus rhythm. During the follow-up of 16 ± 12 months, patients with sinus rhythm showed a lower frequency of rehospitalization due to worsening HF than patients with ATAs (5/41 vs. 7/18, P = 0.019). CONCLUSIONS: Our results showed that intravenous landiolol reduces the heart rate without markedly decreasing blood pressure in patients with ATAs and ADHF. Approximately 70% of the discharged patients were in sinus rhythm, and these patients showed a lower frequency of rehospitalization due to worsening HF (UMIN-CTR no. UMIN000033650).
12 schema:genre article
13 schema:inLanguage en
14 schema:isAccessibleForFree true
15 schema:isPartOf N37f46f01b4d94ff9927e599d7568e017
16 Nd42fff94a964446995759f6a6aba5f62
17 sg:journal.1051855
18 schema:keywords ATAS
19 Atrial tachyarrhythmias (ATAs) lead
20 Intravenous landiolol reduced heart rate
21 Secondary endpoints
22 acute decompensated HF
23 acute decompensated heart failure
24 administration
25 atrial tachyarrhythmias
26 baseline
27 blood pressure
28 changes
29 clinical deterioration
30 days
31 death
32 decompensated heart failure
33 deterioration
34 deterioration of HF
35 dose
36 duration
37 effect
38 endpoint
39 experience
40 failure
41 frequency
42 heart failure
43 heart rate
44 hemodynamics
45 hospital death
46 intravenous landiolol
47 intravenous landiolol administration
48 intravenous β1-blocker landiolol
49 landiolol
50 landiolol administration
51 landiolol reduced heart rate
52 landiolol treatment
53 lead
54 low frequency
55 maintenance dose
56 marked reduction
57 median maintenance dose
58 median treatment duration
59 min
60 months
61 outcomes
62 patients
63 pressure
64 primary endpoint
65 rate
66 reduced heart rate
67 reduction
68 rehospitalization
69 restoration
70 results
71 retrospective study
72 rhythm
73 single-center experience
74 single-center retrospective study
75 sinus rhythm
76 study
77 systolic blood pressure
78 tachyarrhythmias
79 tachyarrhythmias (ATAs) lead
80 total
81 treatment
82 treatment duration
83 ultrashort-acting intravenous β1-blocker landiolol
84 β1-blocker landiolol
85 schema:name Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience
86 schema:pagination 19-26
87 schema:productId N6ece7efca3d64a99aa4d7f87172f9f72
88 N7605bc44336c4e7c8afbf354999b0db7
89 Ned54064d99b3407ca97e78208bdaf5a2
90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112400550
91 https://doi.org/10.1007/s40801-019-0149-1
92 schema:sdDatePublished 2022-01-01T18:50
93 schema:sdLicense https://scigraph.springernature.com/explorer/license/
94 schema:sdPublisher Ne2362cf6931840768cb51b9f1d3186cb
95 schema:url https://doi.org/10.1007/s40801-019-0149-1
96 sgo:license sg:explorer/license/
97 sgo:sdDataset articles
98 rdf:type schema:ScholarlyArticle
99 N37f46f01b4d94ff9927e599d7568e017 schema:volumeNumber 6
100 rdf:type schema:PublicationVolume
101 N38631a8db0d44abab9eb3f6e5dd76552 rdf:first sg:person.01273642053.33
102 rdf:rest Na7e01ef81a8e42caaaed4488be4ae892
103 N3d005f23d05444f4b3dfbe30222d64bb rdf:first sg:person.01204734316.73
104 rdf:rest rdf:nil
105 N6ece7efca3d64a99aa4d7f87172f9f72 schema:name pubmed_id
106 schema:value 30810944
107 rdf:type schema:PropertyValue
108 N7605bc44336c4e7c8afbf354999b0db7 schema:name doi
109 schema:value 10.1007/s40801-019-0149-1
110 rdf:type schema:PropertyValue
111 Na7e01ef81a8e42caaaed4488be4ae892 rdf:first sg:person.01315321616.31
112 rdf:rest N3d005f23d05444f4b3dfbe30222d64bb
113 Nd42fff94a964446995759f6a6aba5f62 schema:issueNumber 1
114 rdf:type schema:PublicationIssue
115 Ne1e13bdb42154c019360ce543c133cb3 rdf:first sg:person.01021613072.27
116 rdf:rest N38631a8db0d44abab9eb3f6e5dd76552
117 Ne2362cf6931840768cb51b9f1d3186cb schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 Ned54064d99b3407ca97e78208bdaf5a2 schema:name dimensions_id
120 schema:value pub.1112400550
121 rdf:type schema:PropertyValue
122 Nee9683b7d3c54dc1b14bfc0892e3d8b9 rdf:first sg:person.010405336441.72
123 rdf:rest Ne1e13bdb42154c019360ce543c133cb3
124 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
125 schema:name Medical and Health Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
128 schema:name Cardiorespiratory Medicine and Haematology
129 rdf:type schema:DefinedTerm
130 sg:journal.1051855 schema:issn 2198-9788
131 2199-1154
132 schema:name Drugs - Real World Outcomes
133 schema:publisher Springer Nature
134 rdf:type schema:Periodical
135 sg:person.01021613072.27 schema:affiliation grid-institutes:grid.410818.4
136 schema:familyName Suzuki
137 schema:givenName Atsushi
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021613072.27
139 rdf:type schema:Person
140 sg:person.010405336441.72 schema:affiliation grid-institutes:grid.410818.4
141 schema:familyName Matsui
142 schema:givenName Yuko
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010405336441.72
144 rdf:type schema:Person
145 sg:person.01204734316.73 schema:affiliation grid-institutes:grid.410818.4
146 schema:familyName Hagiwara
147 schema:givenName Nobuhisa
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204734316.73
149 rdf:type schema:Person
150 sg:person.01273642053.33 schema:affiliation grid-institutes:grid.410818.4
151 schema:familyName Shiga
152 schema:givenName Tsuyoshi
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273642053.33
154 rdf:type schema:Person
155 sg:person.01315321616.31 schema:affiliation grid-institutes:grid.410818.4
156 schema:familyName Arai
157 schema:givenName Kotaro
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315321616.31
159 rdf:type schema:Person
160 sg:pub.10.1007/bf03016588 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029531145
161 https://doi.org/10.1007/bf03016588
162 rdf:type schema:CreativeWork
163 sg:pub.10.1007/s00380-013-0377-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020627110
164 https://doi.org/10.1007/s00380-013-0377-3
165 rdf:type schema:CreativeWork
166 sg:pub.10.1007/s40256-018-0276-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103175695
167 https://doi.org/10.1007/s40256-018-0276-1
168 rdf:type schema:CreativeWork
169 sg:pub.10.1007/s40265-013-0077-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030203642
170 https://doi.org/10.1007/s40265-013-0077-4
171 rdf:type schema:CreativeWork
172 sg:pub.10.1007/s40265-018-0883-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101176136
173 https://doi.org/10.1007/s40265-018-0883-9
174 rdf:type schema:CreativeWork
175 grid-institutes:grid.410818.4 schema:alternateName Department of Cardiology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan
176 schema:name Department of Cardiology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan
177 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...